Proceuticssp. z o.o. in liquidation
KRS: NIP: REGON:
Overview
Status
Active
Registry date
2021-02-08
Share capital
70,000.00 PLN
Financials
Revenue history
Filing timeliness
No financial statement for 2023 – the filing deadline has passed. 1 of 2 financial statements was filed late (for 2022, 83 days late).
- 2023not filed
- 202206/10/2023
- 202130/06/2022
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2022.
Voivodeship · Mazowieckie117,137 / 142,031
Top 82%
Country · Poland417,565 / 495,850
Top 84%
Results vs voivodeship
Revenue
This companyUSD 6.15kMedianUSD 156.04kAverageUSD 5.72m
Net profit
This companyUSD 1.87kMedianUSD 2.43kAverageUSD 291.19k
Operating costs
This companyUSD 3.86kMedianUSD 131.06kAverageUSD 4.92m
Assets
This companyUSD 8.65kMedianUSD 162.63kAverageUSD 10.66m
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Was a VAT taxpayer from 2021-05-07 to 2024-05-09.
Reason for removal: Art. 96 ust. 9a pkt 2 (VAT returns not filed for 3 consecutive months or a quarter)
Debt
No entries in the National Debtors Register (KRZ).
MSiG notices
| Publication date | Event | |
|---|---|---|
| Jan 27, 2023 | Call to creditors |
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Anpharm Przedsiębiorstwo FarmaceutyczneS.A. | $111,469,394.21 | anpharm.pl | ||
| Tarchomińskie Zakłady Farmaceutyczne PolfaS.A. | $102,988,448.02 | polfa-tarchomin.com.pl | ||
| VercoS.A. | $43,577,172.02 | verco.com.pl | ||
| MedicofarmaS.A. | $8,530,473.72 | medicofarma.pl | ||
| VitamaS.A. | $4,287,087.38 | vitama.pl | ||
| Munar PharmaS.A. | $85,649.72 | munar.pl | ||
| Sanford Biotechsp. z o.o. | $2,586.64 | sanfordbiotech.com | ||
| Cefeasp. z o.o. | $294.66 | cefea.pl | ||
| Auxilius PharmaS.A. | $0.83 | auxiliuspharma.com | ||
| Stg25Branch (foreign co.) | – | glagolica.eu |
Change history
| Date | Event | |
|---|---|---|
| 2022-09-01 | Name change (Proceutics → Proceutics Spółka Z Ograniczoną Odpowiedzialnością W Likwidacji) | |
| 2022-08-05 | Liquidation opened | |
| 2021-02-08 | Entered in the register |
FAQ
The company was registered in the Polish National Court Register (KRS) on February 8, 2021.
The headquarters is located at: ul. Adama Mickiewicza 37, 01-625 Warszawa.
The share capital of the company is PLN 70,000 (approx. $18,909).
The latest available financial statement covers the period from January 1, 2022 to December 31, 2022.
In 2022, the company generated total revenue of $6,155, representing an increase of 11564.9% compared to 2021.
Yes, the company recorded a net profit of $1,868 in 2022.
The largest operating cost category falls under other operating costs. This category amounted to $3,861 in 2022, representing 100% of all operating expenses.
Last updated: 2026-03-19